CD22 and cancer: On the other hand, model features that were downregulated in PDAC cfDNA compared to non-cancer cohort were enriched for immune/blood cell relevant genes such as SLFN14 which is important for platelet formation38 and CD22 which is expressed in B cells39 (Fig. 4c).